Trial · NCT00106691
Adverse events334
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 334
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypertension | Vascular disorders | Placebo | 70 | 802 | 70 |
| other | Hypertension | Vascular disorders | Toremifene 20mg | 52 | 787 | 52 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 50 | 802 | 61 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Toremifene 20mg | 46 | 787 | 50 |
| other | Urinary tract infection | Infections and infestations | Placebo | 54 | 802 | 65 |
| other | Urinary tract infection | Infections and infestations | Toremifene 20mg | 41 | 787 | 45 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 46 | 802 | 57 |
| other | Upper respiratory tract infection | Infections and infestations | Toremifene 20mg | 45 | 787 | 53 |
| other | Prostatitis | Reproductive system and breast disorders | Placebo | 49 | 802 | 62 |
| other | Prostatitis | Reproductive system and breast disorders | Toremifene 20mg | 39 | 787 | 43 |
| other | Erectile dysfunction | Reproductive system and breast disorders | Placebo | 42 | 802 | 42 |
| other | Erectile dysfunction | Reproductive system and breast disorders | Toremifene 20mg | 42 | 787 | 43 |
| other | Haematuria | Renal and urinary disorders | Placebo | 38 | 802 | 49 |
| other | Haematuria | Renal and urinary disorders | Toremifene 20mg | 36 | 787 | 43 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 36 | 802 | 41 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Toremifene 20mg | 31 | 787 | 32 |
| other | Dizziness | Nervous system disorders | Placebo | 37 | 802 | 42 |
| other | Dizziness | Nervous system disorders | Toremifene 20mg | 30 | 787 | 32 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 39 | 802 | 42 |
| other | Nasopharyngitis | Infections and infestations | Toremifene 20mg | 28 | 787 | 30 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00106691/events